Back to pipeline

A novel therapy for diastolic heart failure, first in class. Innovative drug for limb ischemia disease and for diseases with loss of muscle mass.

VT2

Therapeutic area
Muscle atrophy, cardiology
Location
Poland / USA
Current phase
Clinical
IP
Back to pipeline
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram